KM Research Hub
← 返回论文库
待处理 入排:排除 图源:待检查

Re: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients with Renal Cell Carcinoma After Progression with Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised, Open-label, Phase 3 Trial.

Matteo Rosellini, Elisa Tassinari, Andrea Marchetti, Veronica Mollica, Francesco Massari

Eur Urol 85(1) 97-98

PMID37777426
PMCID-
DOI10.1016/j.eururo.2023.09.011
发表日期2023-09-30
摘要

摘要

无摘要

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。